UNH

UnitedHealth Group Incorporated

62
Fundamentals51/ 100
Valuation56/ 100
Upside potential71/ 100
Risk potential15/ 100

UNH has the edge over WGS overall, supported by lower modeled downside and stronger fundamentals.

WGS

GeneDx Holdings Corp.

47
Fundamentals36/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential45/ 100

WGS's outlook is improving, though it still trails on the overall score.

UNH Fundamentals

MetricStatus
Stable
Stable
Healthy
Healthy

UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

WGS Fundamentals

MetricStatus
Stable
Weak
Weak
Strong

WGS's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are weak.

UNH PE Valuation

CHEAPFAIREXPENSIVE10x21x31x42x
CHEAPFAIREXPENSIVE10x21x31x42x
LevelPEPriceVs current
Forward18x$405—
Cheap19x$325-20%
Fair23x$410+1.2%
Current23x$405—
Expensive30x$526+30%

Historical ranges are pointers, not guarantees.

UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.

WGS PE Valuation

WGS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 59x next year's earnings.

UNH Forward outlook

MetricOutlook
Strongly improving
Strong growth
Stable
Improving
Moderate
Low

Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.

WGS Forward outlook

MetricOutlook
--
Returning to profit
Growth
Strongly improving
Limited
High

WGS has the edge over UNH on the outlook, with more favorable revenue expectations.

UNH Risk to reward

ScenarioChangePrice
Upside+36%$550.65
Downside-15%$346.07

Calculated from the latest close: $405.13 on Nov 12.

UNH has a better modeled risk to reward balance than WGS, with more potential upside relative to its potential downside.

WGS Risk to reward

ScenarioChangePrice
Upside+84%$95.43
Downside-45%$28.44

Calculated from the latest close: $51.87 on Nov 12.

WGS trails UNH on modeled risk to reward, with less potential upside relative to its potential downside.

UNH Earnings Per Share

Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
Q4 2023: $23.86Q1 2024: $16.38Q2 2024: $15.10Q3 2024: $15.37Q4 2024: $15.51Q1 2025: $23.89Q2 2025: $23.09Q3 2025: $19.17Q4 2025: $13.23Q1 2026: $13.28Q2 2026: $15.58Q3 2026: $17.55Forward: $22.65
QuarterTTM EPSYoY
Forward$22.65+29%
Q3 2026$17.55-8.5%
Q2 2026$15.58-33%
Q1 2026$13.28-44%
Q4 2025$13.23-15%
Q3 2025$19.17+25%
Q2 2025$23.09+53%
Q1 2025$23.89+46%
Q4 2024$15.51-35%

UNH has the edge over WGS on earnings quality, reporting a profit while its opponent remains loss making.

WGS Earnings Per Share

Q4 2023: $-7.23Q1 2024: $-4.97Q2 2024: $-4.23Q3 2024: $-2.90Q4 2024: $-1.94Q1 2025: $-1.39Q2 2025: $0.07Q3 2025: $0.11Q4 2025: $-0.73Q1 2026: $-2.66Q2 2026: $-3.62Q3 2026: $-3.76Forward: $0.88
Q4 2023: $-7.23Q1 2024: $-4.97Q2 2024: $-4.23Q3 2024: $-2.90Q4 2024: $-1.94Q1 2025: $-1.39Q2 2025: $0.07Q3 2025: $0.11Q4 2025: $-0.73Q1 2026: $-2.66Q2 2026: $-3.62Q3 2026: $-3.76Forward: $0.88
QuarterTTM EPSYoY
Forward$0.88—
Q3 2026-$3.76-3518%
Q2 2026-$3.62-5271%
Q1 2026-$2.66-$1.27
Q4 2025-$0.73+$1.21
Q3 2025$0.11+$3.01
Q2 2025$0.07+$4.30
Q1 2025-$1.39+$3.58
Q4 2024-$1.94+$5.29

WGS has swung to a loss: it lost $3.76 per share over the past year, after a profit the year before.

UNH Quarterly Revenue

Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
Q4 2023: $94.4BQ1 2024: $99.8BQ2 2024: $98.9BQ3 2024: $101BQ4 2024: $101BQ1 2025: $110BQ2 2025: $112BQ3 2025: $113BQ4 2025: $113BQ1 2026: $112BQ2 2026: $112BQ3 2026: $113B
QuarterRevenueYoY
Q3 2026$112.7B-0.4%
Q2 2026$112B+0.4%
Q1 2026$111.7B+2%
Q4 2025$113.2B+12%
Q3 2025$113.2B+12%
Q2 2025$111.6B+13%
Q1 2025$109.6B+9.8%
Q4 2024$100.8B+6.8%

UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.

WGS Quarterly Revenue

Q4 2023: $57MQ1 2024: $62MQ2 2024: $71MQ3 2024: $77MQ4 2024: $96MQ1 2025: $87MQ2 2025: $103MQ3 2025: $117MQ4 2025: $121MQ1 2026: $102MQ2 2026: $114MQ3 2026: $123M
Q4 2023: $57MQ1 2024: $62MQ2 2024: $71MQ3 2024: $77MQ4 2024: $96MQ1 2025: $87MQ2 2025: $103MQ3 2025: $117MQ4 2025: $121MQ1 2026: $102MQ2 2026: $114MQ3 2026: $123M
QuarterRevenueYoY
Q3 2026$123.1M+5.4%
Q2 2026$114.4M+11%
Q1 2026$102.3M+17%
Q4 2025$121M+27%
Q3 2025$116.7M+52%
Q2 2025$102.7M+46%
Q1 2025$87.1M+40%
Q4 2024$95.6M+67%

WGS has the edge over UNH on sales, with more consistent year-over-year improvement.

UNH Free Cash Flow

Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
Q4 2023: −$6.2BQ1 2024: $401MQ2 2024: $5.9BQ3 2024: $13BQ4 2024: $1.5BQ1 2025: $4.6BQ2 2025: $6.3BQ3 2025: $5.1BQ4 2025: $160MQ1 2026: $8.1BQ2 2026: $10.3BQ3 2026: $4.3B
QuarterFree cash flowYoY
Q3 2026$4.3B-16%
Q2 2026$10.3B+63%
Q1 2026$8.1B+79%
Q4 2025$160M-89%
Q3 2025$5.1B-61%
Q2 2025$6.3B+6.9%
Q1 2025$4.6B+1037%
Q4 2024$1.5B+$7.6B

UNH has the edge over WGS on cash generation, producing positive trailing cash flow while its opponent burns cash.

WGS Free Cash Flow

Q4 2023: −$32MQ1 2024: −$17MQ2 2024: −$6MQ3 2024: −$5MQ4 2024: −$6MQ1 2025: $4MQ2 2025: $8MQ3 2025: $10MQ4 2025: −$7MQ1 2026: −$39MQ2 2026: −$39MQ3 2026: −$16M
Q4 2023: −$32MQ1 2024: −$17MQ2 2024: −$6MQ3 2024: −$5MQ4 2024: −$6MQ1 2025: $4MQ2 2025: $8MQ3 2025: $10MQ4 2025: −$7MQ1 2026: −$39MQ2 2026: −$39MQ3 2026: −$16M
QuarterFree cash flowYoY
Q3 2026-$15.8M-265%
Q2 2026-$39.1M-586%
Q1 2026-$38.9M-1059%
Q4 2025-$7.4M-$1.2M
Q3 2025$9.6M+$14.6M
Q2 2025$8.1M+$13.9M
Q1 2025$4.1M+$20.9M
Q4 2024-$6.2M+$26M

WGS has burned cash in almost every quarter: −$101M over the past year, against $15M the year before.

UNH Total Shares

Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
Q4 2023: 938MQ1 2024: 922MQ2 2024: 928MQ3 2024: 930MQ4 2024: 929MQ1 2025: 918MQ2 2025: 910MQ3 2025: 908MQ4 2025: 911MQ1 2026: 910MQ2 2026: 906MQ3 2026: 902M
PeriodChange %Net change
Quarterly-0.4%-4M shares
1 year-0.7%-6M shares
3 years-3.6%-34M shares
5 years-5.5%-53M shares
Available history-6.6%-64M shares

UNH has the edge over WGS on shareholder dilution, with a more favorable share count trend.

WGS Total Shares

Q4 2023: 24MQ1 2024: 26MQ2 2024: 27MQ3 2024: 27MQ4 2024: 27MQ1 2025: 28MQ2 2025: 30MQ3 2025: 29MQ4 2025: 29MQ1 2026: 29MQ2 2026: 30MQ3 2026: 30M
Q4 2023: 24MQ1 2024: 26MQ2 2024: 27MQ3 2024: 27MQ4 2024: 27MQ1 2025: 28MQ2 2025: 30MQ3 2025: 29MQ4 2025: 29MQ1 2026: 29MQ2 2026: 30MQ3 2026: 30M
PeriodChange %Net change
Quarterly+0.6%+170K shares
1 year+3.8%+1.1M shares
3 years+16%+4.1M shares

WGS has 30M diluted shares, up 3.8% from a year ago.

UNH Net Leverage

Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
Q4 2023: 1.0xQ1 2024: 1.3xQ2 2024: 1.4xQ3 2024: 1.3xQ4 2024: 1.4xQ1 2025: 1.3xQ2 2025: 1.5xQ3 2025: 1.7xQ4 2025: 2.3xQ1 2026: 2.2xQ2 2026: 1.7xQ3 2026: 1.7x
QuarterNet LeverageStatus
Q3 20261.7xHealthy
Q2 20261.7xHealthy
Q1 20262.2xModerate
Q4 20252.3xModerate
Q3 20251.7xHealthy
Q2 20251.5xHealthy
Q1 20251.3xHealthy
Q4 20241.4xHealthy

UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.

WGS Net Leverage

Q2 2025: -1.5xQ3 2025: -2.3x
Q2 2025: -1.5xQ3 2025: -2.3x
QuarterNet LeverageStatus
Q3 2025-2.3xNet Cash
Q2 2025-1.5xNet Cash

WGS has more cash than debt.

UNH Weekly Momentum

MetricValueStatus
RSI56.4Neutral
Stochastic60.0Neutral

UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).

WGS Weekly Momentum

MetricValueStatus
RSI39.6Neutral
Stochastic14.6Oversold

WGS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).

UNH PE vs Healthcare Sector

MetricUNHSector medianRelative
PE23x26x11% below
PE %472918 pts above

UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.

WGS PE vs Healthcare Sector

MetricWGSSector medianRelative
PEN/A26x—

WGS has no meaningful PE right now: it lost money over the past year.

UNH Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$394.22.8% above
20 week MA$400.51.2% above
50 week MA$361.212% above
100 week MA$376.07.8% above
200 week MA$446.69.3% below

UNH has the edge over WGS on trend strength, trading above more of its moving averages.

WGS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$66.522% below
20 week MA$72.729% below
50 week MA$79.835% below
100 week MA$89.142% below
200 week MA$54.04% below

WGS is in a downtrend: it's below all five of its weekly moving averages, and 4% below its 200-week average.

UNH Yearly ROI

YearStart priceEnd priceROI
2020$296.0$340.8+15%
2021$340.8$495.4+45%
2022$495.4$531.3+7.3%
2023$531.3$526.5-0.9%
2024$526.5$510.0-3.1%
2025$510.0$331.8-35%
2026 YTD$331.8$405.1+22%

UNH has the edge over WGS on returns for 2026, with the stronger performance.

WGS Yearly ROI

YearStart priceEnd priceROI
2020$323.4$382.5+18%
2021$382.5$154.1-60%
2022$154.1$8.02-95%
2023$8.02$2.75-66%
2024$2.75$78.1+2738%
2025$78.1$133.8+71%
2026 YTD$133.8$51.9-61%

WGS's yearly returns have swung widely, from +2738% in 2024 to −95% in 2022. It's down 61% so far in 2026.

Give your agent the market.

Get API key